BamSEC and AlphaSense Join Forces
Learn More

Korsana Biosciences Inc. – Transcripts

NASDAQ: KRSA    
Share price (11/6/26): $31.05    
Market cap (11/6/26): $1.414 billion
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
M&A Revised 04/01/26 Cyclerion Therapeutics, Inc., Korsana Biosciences, Inc. - M&A Call 04/01/26
Other Revised 01/06/26 Cyclerion Therapeutics, Inc. - Special Call 01/06/26
CY 2025
Other Revised 09/24/25 Cyclerion Therapeutics, Inc. - Pre Recorded Special Call 09/24/25
CY 2022
Other Revised 07/28/22 Cyclerion Therapeutics, Inc. - Special Call 07/28/22
Other Revised 06/28/22 Cyclerion Therapeutics, Inc. - Special Call 06/28/22
CY 2021
Other Revised 04/27/21 Cyclerion Therapeutics, Inc. - Special Call 04/27/21
Other Revised 01/14/21 Cyclerion Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-14-2021 12:40 PM 01/14/21
CY 2020
Other Revised 10/14/20 Cyclerion Therapeutics, Inc. - Special Call 10/14/20
Other Revised 07/09/20 Cyclerion Therapeutics, Inc. - Special Call 07/09/20
Other Revised 06/16/20 Cyclerion Therapeutics, Inc. - Shareholder/Analyst Call 06/16/20
Other Revised 01/15/20 Cyclerion Therapeutics, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-13-2020 through Jan-16-2020 01/15/20
CY 2019
Other Revised 10/30/19 Cyclerion Therapeutics, Inc. - Special Call 10/30/19
Earnings Revised 05/13/19 Cyclerion Therapeutics, Inc., Q1 2019 Earnings Call, May 13, 2019 05/13/19